Abstract:Background: The optimal treatment of localized prostate cancer (PCa) remains controversial. Objective: To compare long-term survival among men who underwent radical prostatectomy (RP), brachytherapy (BT), external beam radiation therapy (EBRT), primary androgen deprivation therapy (PADT), or monitoring (active surveillance [AS]/watchful waiting [WW]) for PCa. Design, setting, and participants: This is a cohort study with long-term follow-up from the multicenter, prospective, largely community-based Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry. Men with biopsy-proven, clinical T1-3aN0M0, localized PCa were consecutively accrued within 6 mo of diagnosis and had clinical risk data and at least 12 mo of follow-up after diagnosis available. Outcome measurements and statistical analysis: PCa risk was assessed, and multivariable analyses were performed to compare PCa-specific mortality (PCSM) and all-cause mortality by primary treatment, with extensive adjustment for age and case mix using the Cancer of the Prostate Risk Assessment (CAPRA) score and a well-validated nomogram. Results and limitations: Among 11 864 men, 6227 (53%) underwent RP, 1645 (14%) received BT, 1462 (12%) received EBRT, 1510 (13%) received PADT, and 1020 (9%) were managed with AS/WW. At a median of 9.4 yr (interquartile range 5.8-13.7) after treatment, 764 men had died from PCa. After adjusting for CAPRA score, the hazard ratios for PCSM with RP as the reference were 1.57 (95% confidence interval [CI] 1.24-1.98; p < 0.001) for BT, 1.55 (95% CI 1.26-1.91; p < 0.001) for EBRT, 2.36 (95% CI 1.94-2.87; p < 0.001) for PADT, and 1.76 (95% CI 1.30-2.40; p < 0.001) for AS/WW. In models for long-term outcomes, PCSM differences were negligible for low-risk disease and increased progressively with risk. Limitations include the evolution of diagnostic and therapeutic strategies for PCa over time. In this nonrandomized study, the possibility of residual confounding remains salient. Conclusions: In a large, prospective cohort of men with localized PCa, after adjustment for age and comorbidity, PCSM was lower after local therapy for those with higher-risk disease, and in particular after RP. Confirmation of these results via long-term follow-up of ongoing trials is awaited. Patient summary: We evaluated different treatment options for localized prostate cancer in a large group of patients who were treated mostly in nonacademic medical centers. Results from nonrandomized trials should be interpret with caution, but even after careful risk adjustment, survival rates for men with higher-risk cancer appeared to be highest for patients whose first treatment was surgery rather than radiotherapy, hormones, or monitoring.

The survival outcomes of very young and elderly patients with high-risk prostate cancer after radical treatments: A population-matched study

The Prognosis of Radical Prostatectomy, External Beam Radiotherapy Plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study

Survival Outcomes of Radical Prostatectomy and External Beam Radiotherapy in Clinically Localized High-Risk Prostate Cancer: a Population-Based, Propensity Score Matched Study

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients

Survival Significance of Patients with Low Prostate-Specific Antigen and High-Grade Prostate Cancer after Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy.

Reduced Survival of Young Patients under 55 Years with Metastatic Prostate Cancer: a Population-Based Study

Survival Outcomes of Low Prostate-Specific Antigen Levels and T Stages in Patients with High-Grade Prostate Cancer: a Population-Matched Study.

[Clinicopathologic Characteristics and Prognosis of Early Onset Prostate Cancer].

Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects

The survival outcomes of localized low-risk prostate cancer, a population-based study using NCDB

Prognosis of Prostate Cancer and Bone Metastasis Pattern of Patients: a SEER-based Study and a Local Hospital Based Study from China

Long-term Prognosis and Prognostic Factors of Brachytherapy and Propensity Score Matched Comparisons of the Outcomes Between Brachytherapy and Radical Prostatectomy: a Retrospective Cohort Study.

Localized prostate cancer in older patients: Radical prostatectomy or radiotherapy versus observation

Reduced Cancer-Specific Survival of Low Prostate-Specific Antigen in High-Grade Prostate Cancer: A Population-Based Retrospective Cohort Study.

Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival

Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer

The short-term and oncologic outcomes of younger VS older colorectal cancer patients undergoing primary surgery: a propensity score matching analysis

Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis

Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study

Prognosis of Men with High-Risk Prostate Cancer Stratified by Risk Factors: a Population-Based Retrospective Cohort Study.

Efficacy of brachytherapy versus radical prostatectomy for localized prostate cancer-propensity score-matched comparison